Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

790
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
790
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.

Pulmonology·2026
Same author

Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study.

Vaccine·2026
Same author

Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities.

ERJ open research·2026
Same author

Pulmonary sarcoïdosis presenting as acute hypoxemic respiratory failure.

Respiratory medicine and research·2026
Same author

Considering molecular pharmacology for sarcoidosis treatment.

The Lancet. Respiratory medicine·2026
Same author

Incidence of New Comorbidities After Steroid Use in Patients With Sarcoidosis: An International Cross-Sectional Survey.

Chest·2025

相关实验视频

Updated: May 22, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.7K

晚期的肺部型硬化症.

Florence Jeny1, Dominique Valeyre2, Elyse E Lower3

  • 1Department of Pulmonology, APHP Avicenne University Hospital, INSERM UMR 1272, University Sorbonne Paris Nord, Bobigny, France.

Journal of autoimmunity
|March 15, 2025
PubMed
概括

先进的肺沙尔科毒症可以导致严重的后果,肺纤维化和高血压是主要风险. 目前针对这些晚期肺部疾病的治疗方法缺乏足够的证据来证明其明显的益处.

关键词:
这就是Infliximab.普雷尼索尼 (prednisone) 是一种药物.肺动脉高血压是肺动脉高血压.肺部纤维化 肺部纤维化肺部型硬化症 肺部型硬化症

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

365
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

10.7K

相关实验视频

Last Updated: May 22, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.7K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

365
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

10.7K

科学领域:

  • 肺部医学 肺部医学
  • 类风湿病学 类风湿病学
  • 免疫学 免疫学 免疫学

背景情况:

  • Sarcoidosis 经常影响肺部,表现不同,从无症状病例到致命的结果.
  • 大约25%的沙尔科病患者会患上慢性肺病,这会带来很大的风险.
  • 晚期肺癌型硬化症的特点是疾病进展和增加患病和死亡风险.

研究的目的:

  • 审查晚期肺癌沙尔科病的关键特征和诊断方法.
  • 讨论当前的治疗方法和支持它们的证据,以治疗慢性肺癌类沙丘病.
  • 突出在治疗肺纤维化和高血压中未得到满足的需要.

主要方法:

  • 大规模回顾性研究和临床试验数据的审查.
  • 诊断方式的分析,包括高分辨率计算机断层扫描 (HRCT) 和心声回声.
  • 评估针对慢性炎症,肺高血压和纤维化的治疗策略.

主要成果:

  • 肺纤维化和肺高血压被确定为呼吸衰竭的主要驱动因素,以及肺沙丘症的死亡率.
  • 对于查这些晚期疾病,HRCT和心声回声学至关重要.
  • 虽然已经探索了慢性炎症和肺高血压的治疗方法,但由于研究不足,对与沙尔科毒症相关的肺纤维化中的抗纤维化剂的证据仍然有限.

结论:

  • 晚期肺性沙尔科毒症需要对纤维化和高血压进行警监测.
  • 需要进一步进行强大的临床试验,以确定与沙尔科毒症相关的肺纤维化有效治疗方法.
  • 针对炎症,高血压和纤维化的一种综合性方法对于治疗慢性肺性沙科毒症至关重要.